HCID 178432771, 화합물 → HCID 178497717, 화합물
반응식
[CH3:1][C:2]1[NH:3][C:4]([C:8]2[CH:9]=[C:10]([CH:15]=[CH:16][C:17]=2[CH3:18])[C:11]([O:13][CH3:14])=[O:12])=[C:5]([CH3:7])[N:6]=1.[CH2:19]([O:26][CH2:27]CC1NC(I)=C(C)N=1)[C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1.IC1NC(C)=NC=1C>>[CH2:19]([O:26][CH2:27][CH2:1][C:2]1[NH:3][C:4]([C:8]2[CH:9]=[C:10]([CH:15]=[CH:16][C:17]=2[CH3:18])[C:11]([O:13][CH3:14])=[O:12])=[C:5]([CH3:7])[N:6]=1)[C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1참가 물질
4
실험 절차
The title compound was prepared using standard chemical manipulations and procedures similar to those used for the preparation of compound 5.6, except 2-(2-(benzyloxy)ethyl)-5-iodo-4-methyl-1H-imidazole (compound 227.2) was used in place of 5-iodo-2,4-dimethyl-1H-imidazole (compound 5.5).
출처 및 근거
- ORD 기록
- ord-3edbb205f7ab4893a44f877d55d8ffd2
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09428502B2
반응 노트
불러오는 중…